Amelioration of vasospasm after subarachnoid hemorrhage in transgenic mice overexpressing CuZn-superoxide dismutase

Stroke

Volumn 30, Issue 4, 1999, Pages 867-872

  Kamii, Hideyuki ^a   Kato, Ichiro ^a   Kinouchi, Hiroyuki ^b   Chan, Pak H ^c,d   Epstein, Charles J ^d   Akabane, Atsushi ^a   Okamoto, Hiroshi ^a   Yoshimoto, Takashi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Free radicals; Mice, transgenic; Subarachnoid hemorrhage; Superoxide dismutase; Vasospasm

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; OXYGEN RADICAL; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; MIDDLE CEREBRAL ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TRANSGENIC MOUSE; VASOSPASM;

EID: 0032917996     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.4.867     Document Type: Article

References (71)

1. Macdonald RL, Weir BKA, Saito K, Kanamaru K, Findlay JM, Grace M, Runzer T, Mielke B. Etiology of cerebral vasospasm in primates. J Neurosurg. 1991;75:415-424.
2. Steele JA, Stockbridge N, Maljkovic G, Weir B. Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circ Res. 1991;68:416-423.
3. Asano T, Matsui T. Cerebral vasospasm: a disorder of the local mechanotransduction system in cerebral arteries. Crit Rev Neurosurg. 1993;3:284-294.
4. Chakraborti S, Michael JR. Role of protein kinase C in oxidant-mediated activation of phospholipase A2 in rabbit pulmonary smooth muscle cells. Mol Cell Biochem. 1993;122:9-15.
5. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986;320:454-456.
6. Kamiyama K, Okada H, Suzuki J. The relation between cerebral vasospasm and superoxide: application of an experimental model of vasospasms induced by oxyhemoglobin in cats. Neurol Med Chir (Tokyo). 1981;21:201-209.
7. Shishido T, Suzuki R, Qian L, Hirakawa K. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke. 1994;25:864-868.
8. Macdonald RL, Weir KA, Runzer TD, Grace MGA, Poznansky MJ. Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys. Neurosurgery. 1992;30:529-539.
9. Chan PH, Chu L, Chen SF, Carlson EJ, Epstein CJ. Reduced neurotoxicity in transgenic mice overexpressing human copper-zinc superoxide dismutase. Stroke. 1990;21(suppl III):III-80-III-82.
10. Epstein CJ, Avraham KB, Lovett M, Smith S, Elory-Stein O, Bry C, Groner Y. Transgenic mice with increased CuZn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci U S A. 1987;83:8044-8048.
11. Epstein CJ, Chan PH, Cadet JL, Carlson E, Chen S, Chu L, Fahn S, Jackson-Lewis V, Kinouchi H, Kostic V, Kujirai K, Mizui A, Naini A, Przedborski S, Yang G. Resistance of SOD-transgenic mice to oxidative stress. In: Gage FH, Christen Y, eds. Gene Transfer and Therapy in the Nervous System. Berlin, Germany: Springer-Verlag; 1992:106-117.
12. Chan PH, Yang GY, Chen SF, Carlson E, Epstein CJ. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase. Ann Neurol. 1991;29:482-486.
13. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci U S A. 1991;88:11158-11162.
14. Chan PH. Oxygen radicals in focal cerebral ischemia. Brain Pathol. 1994;4:59-65.
15. Kamii H, Mikawa S, Murakami K, Kinouchi H, Yoshimoto T, Reola L, Carlson E, Epstein CJ, Chan PH. Effects of nitric oxide synthase inhibition on brain infarction in SOD-1-transgenic mice following transient focal cerebral ischemia. J Cereb Blood Flow Metab. 1996;16:1153-1157.
16. Mikawa S, Kinouchi H, Kamii H, Gobbel GT, Chen SF, Carlson E, Epstein CJ, Chan PH. Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. J Neurosurg. 1996;85:885-891.
17. Bederson JB, Germano IM, Guarino L. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat. Stroke. 1995;26:6:1086-1091.
18. Veelken JA, Laing RJ, Jakubowski J. The Sheffield model of subarachnoid hemorrhage in rats. Stroke. 1995;26:7:1279-1283.
19. Matz PG, Sundaresan S, Sharp FR, Weinstein PR. Induction of HSP70 in rat brain following subarachnoid hemorrhage produced by endovascular perforation. J Neurosurg. 1996;85:138-145.
20. Kamii H, Kinouchi H, Sharp FR, Epstein CJ, Sagar SM, Chan PH. Expression of c-fos mRNA after a mild focal cerebral ischemia in SOD-1 transgenic mice. Brain Res. 1994;662:240-244.
21. Kamii H, Kinouchi H, Sharp FR, Chan PH. A model of transient focal cerebral ischemia in the mouse. In: Ohnishi ST, Ohnishi T, eds. Central Nervous System Trauma: Research Techniques. Boca Raton, Fla: CRC Press; 1995:139-146.
22. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke. 1994;25:165-170.
23. Onoda K, Ono S, Ogihara K, Shiota T, Asari S, Ohmoto T, Ninomiya Y. Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg. 1996;85:846-852.
24. Kwan A-L, Lin C-L, Yanamoto H, Howng S-L, Kassell NF, Lee KS. Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery. 1998;42:347-351.
25. Ito U, Ohno K, Yamaguchi T, Tomita H, Inaba Y, Kashima M. Transient appearance of "no-reflow" phenomenon in mongolian gerbils. Stroke. 1980;11:517-521.
26. Yoshida Y, Ikuta F. Three-dimensional architecture of cerebral microvessels with a scanning electron microscope: a cerebrovascular casting method for fetal and adult rats. J Cereb Blood Flow Metab. 1984;4:290-296.
27. MacMillan V, Judge D, Wiseman A, Settles D, Swain J, Davis J. Mice expressing a bovine basic fibroblast growth factor transgene in the brain show increased resistance to hypoxic-ischemic cerebral damage. Stroke. 1993;24:1735-1739.
28. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883-1885.
29. Kondo T, Reaume A, Huang T-T, Carlson E, Murakami K, Chen S, Hoffman E, Scott R, Epstein C, Chan P. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci. 1997;17:4180-4189.
30. Barry K, Gogjian M, Stein B. Small animal model for investigation of subarachnoid hemorrhage and cerebral vasospasm. Stroke. 1979;10: 538-541.
31. Solomon R, Antunes J, Chen R, Bland L, Chien S. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke. 1985;16:58-64.
32. Delgado T, Brismar J, Svendgaard N. Subarachnoid hemorrhage in the rat: angiography and fluorescence microscopy of the major cerebral arteries. Stroke. 1985;16:595-602.
33. Ram Z, Sahar A, Hadani M. Vasospasm due to massive subarachnoid haemorrhage: a rat model. Acta Neurochir (Wien). 1991;110:181-184.
34. Piepgras A, Thome C, Schmiedek P. Characterization of an anterior circulation rat subarachnoid hemorrhage model. Stroke. 1995;26: 2347-2352.
35. Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M. Barrier disruption in the major arteries following experimental subarachnoid hemorrhage. J Neurosurg. 1985;63:433-440.
36. Findlay JM, Weir BKA, Kanamaru K, Espinosa F. Arterial wall changes in cerebral vasospasm. Neurosurgery. 1989;26:736-746.
37. Kim P, Lorenz PR, Sundt TMJ, Vanhoutte PM. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J Neurosurg. 1989;70:108-114.
38. Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg. 1992;76:830-837.
39. Hatake K, Wakabayashi I, Kakishita E, Hishida S. Impairment of endothelium-dependent relaxation factor in human basilar artery after subarachnoid hemorrhage. Stroke. 1992;23:1111-1117.
40. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity on the endothelium-derived relaxing factor. Nature. 1987;327:524-526.
41. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
42. Hino A, Tokuyama Y, Weir B, Takeda J, Yano H, Bell GI, Macdonld RL. Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery. 1996;39:562-568.
43. Hongo K, Ogawa H, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Lehman RM. Comparison of intraluminal and extraluminal inhibitory effects of hemoglobin on endothelium-dependent relaxation of rabbit basilar artery. Stroke. 1988;19:1550-1555.
44. Tsuji T, Weir BKA, Cook DA. Time-dependent effects of extraluminally applied oxyhemoglobin and endothelial removal on vasodilator responses in isolated, perfused canine basilar arteries. Pharmacology. 1989;38:101-112.
45. Kim P, Schini VB, Sundt TMJ, Vanhoutte PM. Reduced reduction of cGMP underlies the loss of endothelium-dependent relaxations in the canine basilar artery after subarachnoid hemorrhage. Circ Res. 1992;70:248-256.
46. Kasuya H, Weir BKA, Nakane M, S. PJ, Johns L, Marton LS, Stefansson K. Nitric oxide synthase and soluble guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg. 1995;82:250-255.
47. Mirsa HP, Fridovich I. The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem. 1972;247:6960-6962.
48. Winterbourn CC, McGrath BM, Carrell RW. Reactions involving superoxide and normal and unstable haemoglobins. Biochem J. 1976;155: 493-502.
49. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-1624.
50. Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, Sugita K. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg. 1994;80:476-483.
51. Medele RJ, Stummer W, Reulen HJ, Steiger HJ. Evidence for peroxidative damage by nitric oxide in experimental chronic cerebral vasospasm. Neurol Res. 1996;18:277-280.
52. Przedborski S, Jackson-Lewis V, Kostic V, Carson E, Epstein CJ, Cadet JL. Superoxide dismutase, catalase, and glutathione peroxidase activities in copper/zinc-superoxide dismutase transgenic mice. J Neurochem. 1992;58:1760-1767.
53. Rasmussen H, Takuwa Y, Park S. Protein kinase C in the regulation of smooth muscle contraction. FASEB J. 1987;1:177-185.
54. Sugawa M, Koide T, Naitoh S, Takato M, Matsui T, Asano T. Phorbol-12,13-diacetate-induced contraction of the canine basilar artery: role of protein kinase C. J Cereb Blood Flow Metab. 1991;11:135-142.
55. Sako M, Nishihara J, Ohta S, Wang J, Sakaki S. Role of protein kinase C in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1993;13:247-254.
56. Matsui T, Kaizu H, Itoh S, Asano T. The role of active smooth muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. J Neurosurg. 1994;80:1-7.
57. Matsui T, Takuwa Y, Johshita H, Yamashita K, Asano T. Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab. 1991;11:143-149.
58. Nishizawa S, Nezu N, Uemura K. Direct evidence for a key role of protein kinase C in the development of vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992;76:635-639.
59. Asano T, Tanishima T, Sasaki T, Sano K. Possible participation of free radical reactions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage. In: Wilkins RH, ed. Cerebral Arterial Spasm. Baltimore, Md: Williams & Wilkins; 1980:190-201.
60. Takuwa Y, Matsui T, Abe Y, Nagafuji T, Yamashita K, Asano T. Alterations in protein kinase C activity and membrane lipid metabolism in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1993;13:409-415.
61. Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K. The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery: an experimental study on cerebral vasospasm. J Neurosurg. 1981;54:357-365.
62. Comair YG, Schipper HM, Brem S. The prevention of oxyhemoglobin-induced endothelial and smooth muscle cytoskelelal injury by deferoxamine. Neurosurgery. 1993;32:58-65.
63. Kanamaru K, Weir BKA, Simpton I, Witbeck T, Grace M. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot. J Neurosurg. 1991;74:454-459.
64. Matsui T, Asano T. Effects of new 21-aminosteroid tirilazad mesylate (U74006F) on chronic cerebral vasospasm in a "two-hemorrhage" model of beagle dogs. Neurosurgery. 1994;34:1035-1039.
65. Sakaki S, Kuwabara H, Ohta S. Biological defense mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysm. Stroke. 1986;17:196-202.
66. Sakaki S, Ohta S, Nakamura H, Takeda S. Free radical reaction and biological defense mechanism in the pathogenesis of prolonged vasospasm in experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1988;8:1-8.
67. Vollmer DG, Kassel NF, Hongo K, Ogawa H, Tsukahara T. Effect of the nonglucocorticoid 21-aminosteroid U74006F on experimental cerebral vasospasm. Surg Neurol. 1989;31:190-194.
68. Vollmer DG, Hongo K, Ogawa H, Tsukahara T, Kassell NF. A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm prophylaxis in a rabbit model of subarachnoid hemorrhage. Neurosurgery. 1991;28:27-32.
69. Watanabe T, Asano T, Shimizu T. Participation of lipoxygenase products from arachidonic acid in the pathogenesis of cerebral vasospasm. J Neurochem. 1988;50:1145-1150.
70. Fujita Y, Shingu T, Gi H, Araki O, Matsunaga M, Handa H. Mechanism of cerebral vasospasm induced by oxyhaemoglobin. In: Brock M, ed. Modern Neurosurgery I. Berlin, Germany: Springer-Verlag; 1982:359-374.
71. Wellum GR, Irvine TW Jr, Zervas NT. Cerebral vasoactivity of heme proteins in vitro: some mechanistic considerations. J Neurosurg. 1982;56:777-783